BIOZYM MEDICAL AS

0352 OSLO

Finances

Return on Equity

−16,34 %

Current Ratio

0,44

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	121 000	243 000	471 000	387 000
Net Income	−66 000	−305 000	−98 000	213 000
Total Assets	786 000	1 132 000	1 414 000	1 569 000
Total Equity	404 000	469 000	789 000	887 000

Income (NOK)	2022	2021	2020	2019
Revenue	121 000	243 000	471 000	387 000
Expenditure	273 000	558 000	380 000	418 000
Operating Profit	−152 000	−316 000	92 000	−31 000
Financial Income	68 000	158 000	0	0
Financial Costs	0	182 000	170 000	0
Financial Balance	68 000	−24 000	−170 000	0
Earnings Before Tax	−84 000	−340 000	−78 000	−31 000
Tax	−19 000	−35 000	20 000	−244 000
Net Income	−66 000	−305 000	−98 000	213 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	616 000	634 000	805 000	1 029 000
Total Current Assets	170 000	499 000	608 000	540 000
Total Assets	786 000	1 132 000	1 414 000	1 569 000
Total Retained Equity	24 000	89 000	409 000	507 000
Total Equity	404 000	469 000	789 000	887 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	383 000	663 000	625 000	681 000
Total Equity and Debt	786 000	1 132 000	1 414 000	1 569 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	121 000	243 000	471 000	387 000
Other Income	0	0	0	0
Revenue	121 000	243 000	471 000	387 000
Cost of Goods Sold	0	41 000	154 000	305 000
Salary Costs	0	0	0	0
Depreciation	0	21 000	34 000	22 000
Impairment	0	0	0	0
Expenditure	273 000	558 000	380 000	418 000
Operating Profit	−152 000	−316 000	92 000	−31 000
Financial Income	68 000	158 000	0	0
Financial Costs	0	182 000	170 000	0
Financial Balance	68 000	−24 000	−170 000	0
Dividends	0	0	0	0
Net Income	−66 000	−305 000	−98 000	213 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	262 000	244 000	224 000	244 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	21 000	56 000
Total Tangible Assets	0	0	21 000	56 000
Total Fiancial Fixed Assets	354 000	390 000	560 000	729 000
Total Fixed Assets	616 000	634 000	805 000	1 029 000
Stock	0	0	0	0
Total Investments	0	0	36 000	36 000
Cash, Bank	27 000	120 000	89 000	40 000
Total Current Assets	170 000	499 000	608 000	540 000
Total Assets	786 000	1 132 000	1 414 000	1 569 000
Total Equity	404 000	469 000	789 000	887 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	6 000	96 000	26 000	23 000
Unpaid Taxes	0	34 000	46 000	35 000
Dividends	0	0	0	0
Other Current Debt	377 000	533 000	553 000	623 000
Total Current Debt	383 000	663 000	625 000	681 000
Total Equity and Debt	786 000	1 132 000	1 414 000	1 569 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−16,34 %	−65,03 %	−12,42 %	24,01 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−125,62 %	−130,04 %	19,53 %	−8,01 %
Current Ratio	0,44	0,75	0,97	0,79
Quick Ratio	0,44	0,75	0,97	0,79
Equity Ratio	0,51	0,41	0,56	0,57
Gross Profit Margin	100 %	83,13 %	67,3 %	21,19 %